NOVARTIS Inactive Instrument
Novartis Share Price CBOE EUROPE EQUITIES
Equities
0QLR
CH0012005267
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 10:44am | NOVARTIS AG : UBS maintains a Buy rating | ZD |
| 02/05 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 48.96B 45.47B 4,086B | Sales 2025 * | 50.79B 47.17B 4,239B | Capitalization | 199B 185B 16,584B |
|---|---|---|---|---|---|
| Net income 2024 * | 10.29B 9.56B 859B | Net income 2025 * | 12.05B 11.19B 1,005B | EV / Sales 2024 * | 4.32 x |
| Net Debt 2024 * | 12.88B 11.96B 1,075B | Net Debt 2025 * | 11.28B 10.47B 941B | EV / Sales 2025 * | 4.13 x |
| P/E ratio 2024 * |
19.3
x | P/E ratio 2025 * |
16.5
x | Employees | - |
| Yield 2024 * |
3.71% | Yield 2025 * |
3.85% | Free-Float | 85.22% |
More Fundamentals
* Assessed data
More news
Latest transcript on Novartis
More recommendations
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 48 | 01/05/01 | |
| Director of Finance/CFO | 59 | 01/03/01 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 16/22/16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 01/13/01 |
Simon Moroney
BRD | Director/Board Member | 65 | 28/20/28 |
| Chairman | 68 | 01/13/01 |
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows:
- oncology (29.9%);
- immunology (17.2%);
- cardiovascular, renal and metabolic diseases (14.1%);
- neuroscience (8.9%).
The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products.
At the end of 2023, Novartis AG had 33 production sites worldwide.
Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
Pharmaceuticals
Calendar
Related indices
| 1st Jan change | Capi. | |
|---|---|---|
| +31.26% | 662B | |
| +21.96% | 546B | |
| -5.31% | 359B | |
| +16.92% | 323B | |
| +4.68% | 289B | |
| +13.68% | 234B | |
| -10.63% | 194B | |
| +4.21% | 167B | |
| -1.81% | 157B |
- Stock Market
- Equities
- NOVN Stock
- 0QLR Stock